To rule out the effect of Bramhi Phant and Jatamansi Phant Shirodhara in Anidra (primary insomnia)

Comparative evaluation of efficacy of Bramhi Phant and Jatamansi Phant Shirodhara in Anidra (primary insomnia)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/06/054322

Enrollment

Registered

2023-06-22

Start date

Unknown

Completion date

Unknown

Last updated

2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F488- Other specified nonpsychotic mental disorders

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of insomnia suffering up to 2 years duration. 2. Patients of either sex with age group 25-65 years. 3. Anidra (insomnia) patients complaining of Angamarda (bodyache), Shirogaurava (heaviness in the head), Shirashoola (headache).

Exclusion criteria

Exclusion criteria: 1. Anidra (insomnia) due to other conditions such as Madatyaya (alcoholism), Abhighata (injury), and other systemic diseases. 2. Patients with secondary insomnia. 3. Psychiatric patients on treatment. Drug induced insomnia. 4. Patients who are already on treatment for insomnia. 5. Patients on hypnotic medicine or other drugs known to cause drowsiness. 6. Pregnant and lactating women. 7. Chronic debilitating diseases. 8. Malignant Hypertension. 9. Pregnant ladies and lactating mothers. 10. Patients contraindicated for Shirodhara karma. 11. Patient not willing for Karma. 12. Individuals whom have had a negative or paradoxical response to an OTC sleep supplement or OTC sleep medication. 13. Individuals with a history of psychiatric illnesses or psychiatric disorders. 14. Individuals who are unaware of specific psychiatric diagnoses but had a history of treatment with antidepressant, neuroleptic medications, or major tranquilizers. 15. Subjects will also be questioned to demonstrate their full understanding of the requirements, demands, and risks of the study and informed of the option to withdraw at any time.

Design outcomes

Secondary

Measure	Time frame
Finding best drug intervention which effective on signs and symptoms of Anidra (primary insomnia within 10 daysTimepoint: at baseline, 3 Days and 10 days	—

Primary

Measure	Time frame
Reliving sign and symptoms of Anidra (primary insomnia in the subjects intervenedTimepoint: at baseline, 3 Days and 10 days	—

Countries

India

Contacts

Public ContactDr Shweta Parwe

Mahatma Gandhi Ayurved College and research Centre

dr.bhu2050@gmail.com8983010655

Outcome results